海辰药业：阿昔莫司胶囊获得药品注册证书

Core Viewpoint - Haicheng Pharmaceutical has received approval from the National Medical Products Administration for the registration of Aximol capsules, which are indicated for patients with high triglyceride levels who do not respond adequately to other treatments [1] Group 1: Product Approval - The product Aximol is approved for use as a replacement or adjunct therapy to lower triglyceride levels in patients [1] - It is specifically indicated for Fredrickson Type IV hyperlipoproteinemia and Fredrickson Type IIb hyperlipoproteinemia [1] - The medication is to be used after dietary changes and other non-drug treatments, such as exercise and weight loss, have been attempted [1]